CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bhargava, M.
Right arrow Articles by Zarnegar, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bhargava, M.
Right arrow Articles by Zarnegar, R.

Cell Growth & Differentiation, Vol 3, Issue 1 11-20, Copyright © 1992 by American Association of Cancer Research


ARTICLES

Scatter factor and hepatocyte growth factor: activities, properties, and mechanism

M Bhargava, A Joseph, J Knesel, R Halaban, Y Li, S Pang, I Goldberg, E Setter, MA Donovan and R Zarnegar
Division of Radiation Oncology, Long Island Jewish Medical Center, New Hyde Park, New York 11042.

Scatter factor (SF) was first identified as a fibroblast-derived protein which disperses (i.e., "scatters") cohesive colonies of epithelium. SF-like proteins were found in human smooth muscle cell conditioned medium, amniotic fluid, and placental tissue. SFs markedly stimulate migration of epithelial, carcinoma, and vascular endothelial cell types at picomolar concentrations. Hepatocyte growth factors (HGFs) were originally described as platelet- and serum-derived proteins which stimulate hepatocyte DNA synthesis. Partial amino acid sequence data for mouse and human SFs indicate significant homology with HGFs. We used biological, biochemical, and immunological assays to evaluate and compare the activities, properties, and mechanisms of action of mouse SF, human SF (fibroblast or placenta derived), and recombinant human HGF (hrHGF). We report the following findings: (a) mouse SF exhibits species-related differences in biological activities relative to the human factors; (b) human SF and hrHGF show significant overlap in biological activities (i.e., hrHGF stimulates motility of multiple normal and carcinoma cell types, whereas human SF stimulates DNA synthesis in several normal cell types); (c) the three factors contain common antigenic determinants; and (d) all three proteins stimulate rapid phosphorylation of tyrosine residues on the c-met protooncogene protein product (the putative receptor for HGF) and on another protein with Mr 110,000. A few biological and immunological differences between human SFs and hrHGF were observed. These may reflect minor variations in amino acid sequence or posttranslational modification related to the sources of the factors. Taken as a whole, our findings suggest that by structural, functional, immunological, and mechanistic criteria, human SF and human HGF are essentially identical.


This article has been cited by other articles:


Home page
Cancer Res.Home page
H. Jin, R. Yang, Z. Zheng, M. Romero, J. Ross, H. Bou-Reslan, R. A.D. Carano, I. Kasman, E. Mai, J. Young, et al.
MetMAb, the One-Armed 5D5 Anti-c-Met Antibody, Inhibits Orthotopic Pancreatic Tumor Growth and Improves Survival
Cancer Res., June 1, 2008; 68(11): 4360 - 4368.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. J. Kim, L. Wang, Y.-C. Su, G. Y. Gillespie, A. Salhotra, B. Lal, and J. Laterra
Systemic Anti-Hepatocyte Growth Factor Monoclonal Antibody Therapy Induces the Regression of Intracranial Glioma Xenografts
Clin. Cancer Res., February 15, 2006; 12(4): 1292 - 1298.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
A. Catizone, G. Ricci, and M. Galdieri
Functional Role of Hepatocyte Growth Factor Receptor During Sperm Maturation
J Androl, November 1, 2002; 23(6): 911 - 918.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. J. Purdie, G. St.J. Whitley, A. P. Johnstone, and J. E. Cartwright
Hepatocyte growth factor-induced endothelial cell motility is mediated by the upregulation of inducible nitric oxide synthase expression
Cardiovasc Res, June 1, 2002; 54(3): 659 - 668.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Muller, A. Morotti, and C. Ponzetto
Activation of NF-{kappa}B Is Essential for Hepatocyte Growth Factor-Mediated Proliferation and Tubulogenesis
Mol. Cell. Biol., February 15, 2002; 22(4): 1060 - 1072.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
R. Wang, L. D. Ferrell, S. Faouzi, J. J. Maher, and J. M. Bishop
Activation of the Met Receptor by Cell Attachment Induces and Sustains Hepatocellular Carcinomas in Transgenic Mice
J. Cell Biol., May 29, 2001; 153(5): 1023 - 1034.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. C. Bowers, S. Fan, K. A. Walter, R. Abounader, J. A. Williams, E. M. Rosen, and J. Laterra
Scatter Factor/Hepatocyte Growth Factor Protects against Cytotoxic Death in Human Glioblastoma via Phosphatidylinositol 3-Kinase- and AKT-dependent Pathways
Cancer Res., August 1, 2000; 60(15): 4277 - 4283.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
K. Lashkari, T. Hirose, J. Yazdany, J. W. McMeel, A. Kazlauskas, and N. Rahimi
Vascular Endothelial Growth Factor and Hepatocyte Growth Factor Levels Are Differentially Elevated in Patients with Advanced Retinopathy of Prematurity
Am. J. Pathol., April 1, 2000; 156(4): 1337 - 1344.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Y. Yoshitomi, S. Kojima, T. Umemoto, K. Kubo, Y. Matsumoto, M. Yano, T. Sugi, and M. Kuramochi
Serum Hepatocyte Growth Factor in Patients with Peripheral Arterial Occlusive Disease
J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2425 - 2428.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
R. E. Carroll, K. A. Matkowskyj, S. Chakrabarti, T. J. McDonald, and R. V. Benya
Aberrant expression of gastrin-releasing peptide and its receptor by well-differentiated colon cancers in humans
Am J Physiol Gastrointest Liver Physiol, March 1, 1999; 276(3): G655 - G665.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
R. Paciucci, M. R. Vila, T. Adell, V. M. Diaz, M. Tora, T. Nakamura, and F. X. Real
Activation of the Urokinase Plasminogen Activator/Urokinase Plasminogen Activator Receptor System and Redistribution of E-Cadherin Are Associated with Hepatocyte Growth Factor-Induced Motility of Pancreas Tumor Cells Overexpressing Met
Am. J. Pathol., July 1, 1998; 153(1): 201 - 212.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Ono, A. Matsumori, T. Shioi, Y. Furukawa, and S. Sasayama
Enhanced Expression of Hepatocyte Growth Factor/c-Met by Myocardial Ischemia and Reperfusion in a Rat Model
Circulation, June 3, 1997; 95(11): 2552 - 2558.
[Abstract] [Full Text]


Home page
J. Cell Sci.Home page
J. Soriano, M. Pepper, T Nakamura, L Orci, and R Montesano
Hepatocyte growth factor stimulates extensive development of branching duct-like structures by cloned mammary gland epithelial cells
J. Cell Sci., January 2, 1995; 108(2): 413 - 430.
[Abstract] [PDF]


Home page
ScienceHome page
I Tsarfaty, S Rong, J. Resau, S Rulong, P. da Silva, and G. Vande Woude
The Met proto-oncogene mesenchymal to epithelial cell conversion
Science, January 7, 1994; 263(5143): 98 - 101.
[Abstract] [PDF]


Home page
J. Cell Sci.Home page
P Clark
Modulation of scatter factor/hepatocyte growth factor activity by cell-substratum adhesion
J. Cell Sci., January 5, 1994; 107(5): 1265 - 1275.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1992 by the American Association of Cancer Research.